Pharmacogenetics now surrounds us and is an efficient tool to prevent disease or to guide drug therapy. By studying polymorphisms in the genes coding for metabolism enzymes and drug transporters, we can have clues to help choose the right drug or adjust drug dosage. Not to mention that pharmacogenetics is the ideal companion for therapeutic drug monitoring for a comprehensive treatment optimization. Treatment failure and adverse drug reactions may, at least partly, be explained with pharmacogenetics and we have never been so close to large-scale implementation of this strategy.
In this episode, the Chair and Vice-Chair of the IATDMCT pharmacogenetic scientific committee will give us an overview of everything you need to know on pharmacogenetics.
Erika is director of the Experimental and Clinical Pharmacology Unit of the Aviano Oncology Referral Centre, and contract professor at the School of Clinical Pharmacology and Toxicology, University of Trieste, Italy.
Jesse is a professor of Clinical Pharmacy and Pharmacogenetics, and Chair of the Laboratory of the Department of Clinical Pharmacy and Toxicology, at the Leiden University Medical Center, in the Netherlands.
![]() |
![]() |
![]() |
The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.